Product Description
Innotox® Product Overview
Innotox® is a revolutionary botulinum toxin type A product, distinguished as the world’s first liquid formulation. It is developed without animal-derived ingredients or human serum albumin, enhancing its safety profile. Its liquid form eliminates the need for dilution, offering convenience and reducing risks of contamination during preparation. Manufactured by Medytox, Innotox® is a cutting-edge solution for treating moderate to severe glabellar wrinkles, demonstrating efficacy and safety in multiple clinical studies.
Key Features:
- Active Ingredient: Clostridium botulinum toxin type A (Hall strain)
- Formulation: Liquid, ready-to-use
- Manufacturing Method: Excludes human serum albumin and animal-derived ingredients
- Indications: Temporary improvement of moderate to severe glabellar wrinkles
- Packaging: Available in single-use vials (25U and 50U).
Innotox® Indications for Use
Innotox® is approved for adults aged 20 to 65 years for the temporary improvement of glabellar wrinkles. It targets wrinkles caused by the activity of the corrugator and procerus muscles, delivering precise and effective results.
Primary Indications:
- Moderate to severe glabellar wrinkles
- Temporary smoothing of facial lines associated with muscle activity.
Innotox® Dosage Information
Innotox® eliminates the need for dilution, simplifying its application process. The dosage is precise, ensuring effective treatment with minimal preparation effort.
Dosage Protocol:
- Standard Dosage for Glabellar Wrinkles: 0.5 mL (equivalent to 20 Units)
- Unit Distribution: 4 Units per 0.1 mL
- No Dilution Required: Ready-to-use liquid formulation eliminates variability caused by manual dilution.
Innotox® Side Effects and Precautions
Innotox® boasts a strong safety profile, yet, like all botulinum toxin products, it may cause mild side effects. These are typically localized and temporary.
Common Side Effects:
- Redness, Swelling, and Bruising: Observed at the injection site
- Mild Discomfort or Pain: Short-lived and self-limiting
- Rare Systemic Reactions: Mild headaches or temporary drooping of nearby facial muscles.
Precautions:
- Proper Technique: Administer only by trained professionals
- Contraindications: Avoid use in patients with hypersensitivity to botulinum toxin or active infections at the injection site
- Storage: Refrigerate at 2-8°C; do not freeze.
Innotox® Clinical Studies or Real-World Outcomes
In clinical evaluations, Innotox® demonstrated superior performance in improving glabellar wrinkles, maintaining results longer than competitors in similar studies.
Key Findings:
- Efficacy: Comparable to traditional botulinum toxin type A products at 4 weeks; superior retention at 16 weeks
- Long-Term Benefits: Sustained wrinkle improvement observed up to 4 months
- User-Friendly Application: Ready-to-use formulation increases safety by minimizing errors during preparation.
Patient Observations:
- High Satisfaction: Majority of patients noted visible improvement in wrinkle appearance within the first 2 weeks
- Minimal Downtime: Rapid recovery due to reduced preparation steps and precise application.
Innotox® Composition and Active Ingredients
Innotox®’s unique formulation ensures stability, safety, and effectiveness.
Key Ingredients:
- Clostridium botulinum toxin type A: Neurotoxin targeting muscle activity
- Non-Animal Derived Stabilizers: Ensures safety and long-term product stability
- Liquid Base: Allows direct use without dilution.
Innotox® Drug Interactions
As a localized treatment, Innotox® has minimal systemic absorption and limited drug interactions. However, certain considerations apply.
Important Considerations:
- Concurrent Neurotoxin Treatments: Avoid overlapping applications in adjacent muscle groups
- Interaction with Anticoagulants: Use cautiously in patients prone to bruising
- Immunosuppressive Therapy: Reduced efficacy in immunocompromised patients.